Trial Profile
Retrospective Study of Daclatasvir (DCV) and Asunaprevir (ASV) therapy for Patients with Chronic Hepatitis C Virus (HCV)-1b Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2018
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 05 Jun 2018 New trial record